PMC:7784786 / 38-308
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4 | 13-21 | Species | denotes | patients | Tax:9606 |
| 5 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 24 | 251-254 | Gene | denotes | CD6 | Gene:923 |
| 29 | 245-250 | Species | denotes | human | Tax:9606 |
| 33 | 193-203 | Chemical | denotes | Itolizumab | MESH:C000597346 |
| 36 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 27-52 | Phenotype | denotes | cytokine-release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
| T2 | 116-141 | Phenotype | denotes | cytokine-release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 77-85 | Sentence | denotes | Abstract |
| T3 | 86-192 | Sentence | denotes | In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. |